1. Home
  2. STOK

as 06-20-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.

Founded: 2014 Country:
United States
United States
Employees: N/A City: BEDFORD
Market Cap: 751.0M IPO Year: 2019
Target Price: $21.67 AVG Volume (30 days): 727.1K
Analyst Decision: Strong Buy Number of Analysts: 8
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.41 EPS Growth: N/A
52 Week Low/High: $3.35 - $17.58 Next Earning Date: 08-05-2024
Revenue: $7,845,000 Revenue Growth: -46.10%
Revenue Growth (this year): 69.83% Revenue Growth (next year): 22.72%

STOK Daily Stock ML Predictions

Stock Insider Trading Activity of Stoke Therapeutics Inc. (STOK)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Kaye Edward M. MD STOK CEO May 20 '24 Sell $15.39 39,686 $610,783.41 29,664 SEC Form 4
Kaye Edward M. MD STOK CEO May 20 '24 Sell $16.05 2,664 $42,745.74 27,000 SEC Form 4
Allan Jonathan STOK GENERAL COUNSEL & CORP SEC May 20 '24 Sell $15.04 8,599 $129,327.24 2,598 SEC Form 4
Ticho Barry STOK CHIEF MEDICAL OFFICER May 1 '24 Sell $11.37 10,000 $113,653.00 2,485 SEC Form 4
Skorpios Trust STOK 10% Owner Apr 17 '24 Sell $11.60 3,600,000 $41,760,000.00 10,843,681 SEC Form 4
Ticho Barry STOK CHIEF MEDICAL OFFICER Apr 1 '24 Sell $13.23 9,426 $124,684.30 2,485 SEC Form 4
Allan Jonathan STOK GENERAL COUNSEL & CORP SEC Mar 28 '24 Sell $13.19 5,026 $66,286.91 2,698 SEC Form 4
Allan Jonathan STOK GENERAL COUNSEL & CORP SEC Mar 28 '24 Sell $13.81 100 $1,381.00 2,598 SEC Form 4
Ticho Barry STOK CHIEF MEDICAL OFFICER Mar 15 '24 Sell $6.10 4,116 $25,101.84 11,469 SEC Form 4
Tulipano Stephen J STOK CFO Mar 15 '24 Sell $6.10 4,116 $25,101.84 20,746 SEC Form 4
Nash Huw M. STOK COO & CBO Mar 15 '24 Sell $6.10 4,116 $25,101.84 11,329 SEC Form 4
Allan Jonathan STOK GENERAL COUNSEL & CORP SEC Mar 15 '24 Sell $6.10 2,349 $14,325.61 7,724 SEC Form 4
Kaye Edward M. MD STOK CEO Mar 15 '24 Sell $6.10 11,150 $67,999.39 69,350 SEC Form 4
Ticho Barry STOK CHIEF MEDICAL OFFICER Mar 1 '24 Sell $7.75 10,000 $77,469.00 2,485 SEC Form 4
Ticho Barry STOK CHIEF MEDICAL OFFICER Feb 1 '24 Sell $4.80 10,000 $47,991.00 6,981 SEC Form 4
Ticho Barry STOK Chief Medical Officer Jan 2 '24 Sell $5.74 10,000 $57,352.00 16,981 SEC Form 4

Share on Social Networks: